Correlation Between Labiana Health and Vytrus Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Labiana Health and Vytrus Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Labiana Health and Vytrus Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Labiana Health SA and Vytrus Biotech SA, you can compare the effects of market volatilities on Labiana Health and Vytrus Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Labiana Health with a short position of Vytrus Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Labiana Health and Vytrus Biotech.

Diversification Opportunities for Labiana Health and Vytrus Biotech

0.82
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Labiana and Vytrus is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Labiana Health SA and Vytrus Biotech SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vytrus Biotech SA and Labiana Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Labiana Health SA are associated (or correlated) with Vytrus Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vytrus Biotech SA has no effect on the direction of Labiana Health i.e., Labiana Health and Vytrus Biotech go up and down completely randomly.

Pair Corralation between Labiana Health and Vytrus Biotech

Assuming the 90 days trading horizon Labiana Health SA is expected to under-perform the Vytrus Biotech. In addition to that, Labiana Health is 3.65 times more volatile than Vytrus Biotech SA. It trades about -0.17 of its total potential returns per unit of risk. Vytrus Biotech SA is currently generating about 0.04 per unit of volatility. If you would invest  220.00  in Vytrus Biotech SA on August 24, 2024 and sell it today you would earn a total of  2.00  from holding Vytrus Biotech SA or generate 0.91% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy100.0%
ValuesDaily Returns

Labiana Health SA  vs.  Vytrus Biotech SA

 Performance 
       Timeline  
Labiana Health SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Labiana Health SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental drivers remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Vytrus Biotech SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vytrus Biotech SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Labiana Health and Vytrus Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Labiana Health and Vytrus Biotech

The main advantage of trading using opposite Labiana Health and Vytrus Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Labiana Health position performs unexpectedly, Vytrus Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vytrus Biotech will offset losses from the drop in Vytrus Biotech's long position.
The idea behind Labiana Health SA and Vytrus Biotech SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Global Correlations
Find global opportunities by holding instruments from different markets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing